Response to subthreshold micropulse laser treatment in the prophylaxis of diabetic macular oedema: A preliminary study
Acta Ophthalmologica · 2026
DOI: 10.1111/aos.17548 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Ophthalmologica, 2026. Verfasst von Barbara Sabal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Visual Acuity, Laser Coagulation. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Purpose
To evaluate the use of subthreshold micropulse laser (SMPL) in the prevention and management of mild diabetic macular oedema (DME).
Methods
This prospective, randomised and sham‐controlled study included 159 eyes (123 patients) with diabetic retinopathy, central retinal thickness (CRT) ≤ 325 μm, and best‐corrected visual acuity (BCVA) ≥ 80 ETDRS letters. The participants were assigned to either SMPL treatment ( n = 103) or sham therapy ( n = 56). Ophthalmic evaluations were performed at baseline (T1), 3 months (T2) and 12 months (T3) to assess BCVA and optical coherent tomography (OCT) parameters, including CRT, macular thickness (MT), macular volume (MV), and hyperreflective spots (HRS).
Results
In the SMPL group, BCVA improved after 3 months (T2 > T1; p = 0.002); MT decreased after 12 months (T2, T1 > T3; p < 0.001); MV decreased after 12 months (T2, T1 > T3; p < 0.001); HRS count decreased after 3 and 12 months (T1 > T2, T3, p < 0.001). The decrease in CRT after 3 months was greater in the SMPL group ( p = 0.003). The need for rescue therapy was lower in the SMPL group (9.7% vs. 19.6%, p = 0.007). BCVA, CRT, MV, MT and HRS remained stable in the sham group, while microaneurysms count was stable in both groups.
Conclusion
SMPL is safe and effective for the prophylaxis of mild DME, as it reduces MT and MV while keeping BCVA stable. The decreased need for rescue anti‐vascular endothelial growth factor therapy suggests that it may delay or reduce intravitreal injections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair and Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
- Department of Ophthalmology, John Paul II Municipal Hospital, Rzeszow, Poland.
- Scientific Research Facility, Branch in Bielsko-Biala, Medical University of Silesia, Katowice, Poland.
ORCID-Profile: Barbara Sabal
Zitieren
APA
Sabal, B., Wylęgała, E., & Teper, S. (2026). Response to subthreshold micropulse laser treatment in the prophylaxis of diabetic macular oedema: A preliminary study. Acta Ophthalmologica. https://doi.org/10.1111/aos.17548
Vancouver
Sabal B, Wylęgała E, Teper S. Response to subthreshold micropulse laser treatment in the prophylaxis of diabetic macular oedema: A preliminary study. Acta Ophthalmologica. 2026. doi:10.1111/aos.17548
BibTeX
@article{Sabal2026,
author = {Sabal, Barbara and Wylęgała, Edward and Teper, Sławomir},
title = {Response to subthreshold micropulse laser treatment in the prophylaxis of diabetic macular oedema: A preliminary study},
journal = {Acta Ophthalmologica},
year = {2026},
doi = {10.1111/aos.17548}
}
EUVIMED